Trademark: THE BRAIN CANCER CENTRE MANY MINDS. ONE FOCUS. 2215390
Word
THE BRAIN CANCER CENTRE MANY MINDS. ONE FOCUS.
Device Descrption:
BRAINS,STYLISED FORM QUOTATION-BALLOON ATOP LTR I
ID
2215390
Trademark Type
Figurative
Status
Registered: Registered/protected
Application Date
30 September 2021
Registration Date
30 September 2021
Renewal Date
30 September 2031
Owner(s)
Service
FB Rice Pty Ltd
Goods and Services:
Class 41:
Education; provision of training and further education specifically in the field of scientific and medical research
Education; provision of training and further education specifically in the field of scientific and medical research
Class 42:
The provision of services in respect of medical and scientific research; research and development; medical research; pharmaceutical research; diagnostic research and development; consulting and reporting in the fields of medical and pharmaceutical research; research and development services including in relation to development of programmes for the treatment of diseases including cancer, development and ageing, and immune health and infection; research and development in the field of bioinformatics, cancer biology, cell death, cell signalling, clinical translation, colony stimulating factors, computational biology, epigenetics, haematology, immunology, immunotherapy, infection, inflammation, personalised medicine, stem cells, systems biology; research and development in the field of antibody technologies, drug discovery, flow cytometry, genomics, imaging, medicinal chemistry, proteomics, structural biology, and vaccine development; provision of information in relation to the foregoing
The provision of services in respect of medical and scientific research; research and development; medical research; pharmaceutical research; diagnostic research and development; consulting and reporting in the fields of medical and pharmaceutical research; research and development services including in relation to development of programmes for the treatment of diseases including cancer, development and ageing, and immune health and infection; research and development in the field of bioinformatics, cancer biology, cell death, cell signalling, clinical translation, colony stimulating factors, computational biology, epigenetics, haematology, immunology, immunotherapy, infection, inflammation, personalised medicine, stem cells, systems biology; research and development in the field of antibody technologies, drug discovery, flow cytometry, genomics, imaging, medicinal chemistry, proteomics, structural biology, and vaccine development; provision of information in relation to the foregoing